In July 2020, the US Food and Drug Administration (FDA) published the draft guidance entitled Cannabis and Cannabis Derived Compounds: Quality Considerations for Clinical Research …
Patient enrolment is a pivotal aspect of any clinical trial. Without a large enough subject group, trial results may lack statistical significance as not enough …
The introduction of the General Data Protection Regulation (Regulation (EU) 2016/679) (“GDPR”) was a painful process for many companies as databases were stripped, new practices …
While more information needs to be learned about COVID-19, it has become clear that poorer outcomes and the risk of mortality in the US population …
Risk-based monitoring (RBM) may be a relatively recent phenomenon, but it has become a commonly used methodology in clinical trials as evidence of its benefits …
Clinical trials are a cornerstone of drug development, providing scientific evidence on the safety and efficacy of novel pharmaceutical compounds. While traditional trials have effectively …
Maintaining compliance can be a relentless drain on resources. Alternatively, business can make good use of the data collected for compliance to gain actionable business …
The global crisis caused by the coronavirus has disrupted our personal and professional lives in ways that seemed inconceivable only a fewmonths ago. This is …
A staggering number of clinical trials fail to meet recruitment goals, leading to delays, early termination, or inability to draw conclusions at trial completion due …
Working in the clinical trial space teaches you a lot about resilience, there is a sense of duty to get things done, and this intensifies, …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.